资讯

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ...
The funding is set to accelerate the development of Isomorphic’s AI drug design engine and advance clinical programmes.
Isomorphic Labs is the secretive AI life science startup spun out of Google DeepMind with the goal of solving all disease ...
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
“This funding will further turbocharge the development of our next-generation AI drug design ... and accelerate drug discovery. The company co-developed AlphaFold 3 with Google DeepMind, an ...
which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday. Google ...
Lilly and Novartis have collectively pledged almost $3 billion to their partnerships with Isomorphic signed last year, which ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...